Fingerprint
Dive into the research topics of 'Combination therapy for Type 2 diabetes: Repaglinide plus rosiglitazone'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination therapy for Type 2 diabetes: Repaglinide plus rosiglitazone
Philip Raskin, J. McGill, M. F. Saad, J. M. Cappleman, W. Kaye, N. Khutoryansky, P. M. Hale
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations